White Paper

How Digital MSK Biomarkers Can Improve Injury Recovery Outcomes

Over 90% of musculoskeletal (MSK) injuries can be treated without surgery — especially now that we have sophisticated biomarker data to inform the severity and recovery of MSK injuries.

White Paper Summary

Medical technologies may have come a long way in recent decades, but the process of treating musculoskeletal injuries hasn’t changed much aside from the operating room and the use of biologics.

Orthopedists, physical therapists and other MSK health care providers are likely to take a conservative approach to care, avoiding surgery whenever possible. If you walk into a PT’s office, you might see goniometers and other dated tools being used to measure a patient’s range of motion. Others may rely on patient-reported outcomes (PROs) rather than more objective, data-driven measures for analyzing patient recovery.

Even basic technologies like telemedicine — which became a staple during the pandemic — have “very low utilization in orthopedics, in musculoskeletal care,” said Dr. Michael Oberlander, chief medical officer for FIGUR8. “Orthopedic surgeons have generally not been holistically incorporating this technology into patient care.”

While orthopedic surgeons have been slow to adopt new digital tools, patients are demanding it. Virtual appointments became commonplace during COVID. Patients love their convenience, especially for check-in appointments during an ongoing recovery process.

“The general public was introduced to digital health, and they saw the ability of health care providers to evaluate and treat patients without seeing them in person. It can save significant time, money and hassles associated with routine follow-up care,” Oberlander said.

To learn more, visit their website.

FIGUR8, a MIT spin-off company, is the innovation leader in musculoskeletal (MSK) biometrics, redefining the way MSK health is measured to deliver improved clinical and financial outcomes. Our bioMotion Assessment Platform (bMAP) is the first practical solution for measuring MSK function precisely and objectively, at any point of care. This technology enables patients, providers, and payers to have a full picture view regarding joint motion and muscle function during dynamic activities; using movement as a biomarker to improve MSK health. Our powerful, lightweight system combines clinically smart biosensors, intuitive software and artificial intelligence (AI) to improve MSK health — from injury through full recovery.

More from Risk & Insurance